Sigyn Therapeutics, Inc. Quarterly Quick Ratio in % from Q2 2016 to Q3 2024

Taxonomy & unit
ratio: %
Description
The acid-test ratio, also called the quick ratio, is a metric used to see if a company is positioned to sell assets within 90 days to meet immediate expenses.
Summary
Sigyn Therapeutics, Inc. quarterly Quick Ratio history and growth rate from Q2 2016 to Q3 2024.
  • Sigyn Therapeutics, Inc. Quick Ratio for the quarter ending September 30, 2024 was 1.25 %, a 25.7% decline year-over-year.
Quick Ratio, Quarterly (%)
Quick Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 1.25 -0.43 -25.7% Sep 30, 2024
Q2 2024 1.29 -0.71 -35.6% Jun 30, 2024
Q1 2024 1.34 -1.11 -45.2% Mar 31, 2024
Q4 2023 1.48 -1.71 -53.6% Dec 31, 2023
Q3 2023 1.67 -2.37 -58.7% Sep 30, 2023
Q2 2023 1.99 -17 -89.5% Jun 30, 2023
Q1 2023 2.45 -36.5 -93.7% Mar 31, 2023
Q4 2022 3.19 -56.9 -94.7% Dec 31, 2022
Q3 2022 4.04 -77.7 -95.1% Sep 30, 2022
Q2 2022 19 -94.8 -83.3% Jun 30, 2022
Q1 2022 38.9 -12.1 -23.7% Mar 31, 2022
Q4 2021 60.1 +27.1 +82.2% Dec 31, 2021
Q3 2021 81.8 +45.7 +127% Sep 30, 2021
Q2 2021 114 +91.8 +418% Jun 30, 2021
Q1 2021 51 +30.4 +148% Mar 31, 2021
Q4 2020 33 +13.4 +68.3% Dec 31, 2020
Q3 2020 36.1 +20.6 +133% Sep 30, 2020
Q2 2020 22 +6.24 +39.7% Jun 30, 2020
Q1 2020 20.6 +4.59 +28.7% Mar 31, 2020
Q4 2019 19.6 +3.52 +21.9% Dec 31, 2019
Q3 2019 15.5 -1.03 -6.25% Sep 30, 2019
Q2 2019 15.7 Jun 30, 2019
Q1 2019 16 Mar 31, 2019
Q4 2018 16.1 Dec 31, 2018
Q3 2018 16.5 Sep 30, 2018
Q3 2016 39.9 Sep 30, 2016
Q2 2016 41.9 Jun 30, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.